Santagata Davide: Atypical Vascular Events Revealing Underlying Clonal Autoinflammation
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about the recent article published in Internal and Emergency Medicine, co-authored by him and his colleagues, adding:
“Sometimes an unusual thrombosis is much more than a vascular event.
We are excited to share our new case report published in Internal and Emergency Medicine
‘Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease’
In this case, extensive splanchnic vein thrombosis was the first major clue to an underlying VEXAS syndrome, later confirmed by UBA1 mutation testing.
The report underlines three key clinical messages: unusual-site thrombosis may hide a systemic hematologic/autoinflammatory disorder, the peripheral blood smear can offer an early and accessible diagnostic clue, and management often requires balancing anticoagulation with inflammation control.
Congratulations to all co-authors for this collaborative work.”
Title: Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease
Authors: Davide Santagata, Matteo Molteni, Elena Epis, Francesco Dentali, Leonardo Campiotti

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments